Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1998-4-8
|
pubmed:abstractText |
To evaluate survival and time to metastatic disease in patients treated for localized prostatic carcinoma in a Phase III radiotherapy (RT) protocol, Radiation Therapy Oncology Group (RTOG) 77-06. Patients with T18N0M0 (A2) or T2N0M0 (B) disease after lymphangiogram (LAG) or staging laparotomy (SL) were randomized between prophylactic radiation to the pelvic lymph nodes and prostatic bed vs. prostatic bed alone. The outcome of both treatment arms, as well as a comparison of the LAG group, to that of the SL group, are updated.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0360-3016
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
769-82
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9531360-Aged,
pubmed-meshheading:9531360-Aged, 80 and over,
pubmed-meshheading:9531360-Humans,
pubmed-meshheading:9531360-Lymphatic Irradiation,
pubmed-meshheading:9531360-Male,
pubmed-meshheading:9531360-Middle Aged,
pubmed-meshheading:9531360-Neoplasm Staging,
pubmed-meshheading:9531360-Pelvis,
pubmed-meshheading:9531360-Prospective Studies,
pubmed-meshheading:9531360-Prostatic Neoplasms,
pubmed-meshheading:9531360-Radiotherapy Dosage,
pubmed-meshheading:9531360-Survival Rate,
pubmed-meshheading:9531360-Treatment Outcome
|
pubmed:year |
1998
|
pubmed:articleTitle |
Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG #77-06, a phase III study for T1BN0M0 (A2) and T2N0M0 (B) prostate carcinoma.
|
pubmed:affiliation |
Albert Einstein Medical Center, Philadelphia, PA 19141, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Clinical Trial, Phase III
|